Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-23

FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for buprenorphine hydrochloride submitted by Par Health USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine Hydrochloride (Buprenorphine hydrochloride)

Snippet

SUPPL AP for BUPRENORPHINE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE)